Previous 10 | Next 10 |
2024-06-06 06:59:21 ET Read the full article on Seeking Alpha For further details see: Vanda Pharma surges on report of $8 takeover offer from Cycle Pharma
2024-05-30 17:57:18 ET More on Vanda Pharmaceuticals Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much Vanda Pharmaceuticals rejects sweetened bid from Future Pak Vanda reports po...
Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference PR Newswire WASHINGTON , May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jeffe...
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY® PR Newswire WASHINGTON , May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug App...
Vanda Pharmaceuticals Announces Presentations at SLEEP 2024 PR Newswire WASHINGTON , May 29, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2024, to be held in Houston, TX from June 1 through Ju...
2024-05-24 16:55:06 ET More on Vanda Pharmaceuticals Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much Vanda reports positive Phase 3 data for motion sickness drug Vanda Pharmaceu...
Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders PR Newswire WASHINGTON , May 24, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)...
2024-05-15 11:26:48 ET More on Vanda Pharmaceuticals Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much Vanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46M Vanda Pharmaceu...
Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness PR Newswire • New Drug Application expected to be submitted in Q4 2024 WASHINGTON , May 15, 2024 /PRNewswire/ -- Vanda Pharmaceuticals In...
2024-05-08 21:48:11 ET Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Conference Call May 08, 2024 04:30 pm ET Company Participants Mihael Polymeropoulos - President, Chairman and CEO Kevin Moran - CFO Tim Williams - Senior Vice President and General Counsel...
News, Short Squeeze, Breakout and More Instantly...
Vanda Pharmaceuticals Inc. Company Name:
VNDA Stock Symbol:
NASDAQ Market:
Vanda Pharmaceuticals Inc. Website:
Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex PR Newswire WASHINGTON , July 1, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. District Court for the District of ...
Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders PR Newswire WASHINGTON , June 19, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq...
A look at the top 10 most actives in the United States Nauticus Robotics Inc. (KITT) rose 29.5% to $0.1787 on volume of 92,016,620 shares Freight Technologies Inc. (FRGT) rose 92.0% to $1.2 on volume of 65,878,105 shares Aethlon Medical Inc. (AEMD) rose 68.2% to $0.7379 on volume of 48,98...